Literature DB >> 11368780

Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages.

E M Lindholm1, A M Palmer, A Graham.   

Abstract

Elevated plasma levels of triacylglycerol-rich lipoproteins (TGRLP) are associated with increased risk of atherogenesis and abnormal reverse cholesterol transport, as illustrated in Type II diabetes. Here we examine the effect of plasma triacylglycerol-rich or cholesteryl ester-rich lipoproteins on the secretion of nascent apolipoprotein E (apoE)-containing lipoprotein E (LpE) particles by human (THP-1) macrophages. As expected, preincubation with low-density lipoprotein (LDL) yielded small but significant increases in total cellular cholesterol content and also the secretion of apoE by macrophages. By contrast, preincubation with TGRLP resulted in higher, dose-dependent, increases in apoE secretion that reflected, but were not dependent on, cellular triacylglycerol accumulation. Secreted apoE was incorporated into a pre-beta migrating LpE fraction that differed in lipid composition and flotation density depending on preincubation conditions. Specifically, the LpE-containing lipoprotein fraction produced by macrophages preincubated with TGRLP was cholesterol-poor, markedly heterogeneous and of higher peak flotation density (d 1.14-1.18) when compared with particles produced after preincubation with LDL. Both the conditioned medium and the isolated (d<1.21) LpE-containing fraction, yielded by macrophages preincubated with TGRLP, seemed poorer at inducing cholesterol efflux than the equivalent fractions from cells preincubated with LDL, as judged by [(3)H]cholesterol efflux from untreated 'naïve' macrophages. Thus, although the interaction of TGRLP with macrophages can enhance apoE output from these cells, the LpE particles produced seem to be relatively inefficient mediators of cholesterol efflux. These factors might contribute to the increased risk of atherosclerosis in individuals with Type II diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368780      PMCID: PMC1221864          DOI: 10.1042/0264-6021:3560515

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.

Authors:  M W Huff; D B Miller; B M Wolfe; P W Connelly; C G Sawyez
Journal:  J Lipid Res       Date:  1997-07       Impact factor: 5.922

2.  Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM.

Authors:  M Carantoni; F Abbasi; L Chu; Y D Chen; G M Reaven; P S Tsao; B Varasteh; J P Cooke
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

3.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

4.  Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux.

Authors:  H S Kruth; S I Skarlatos; P M Gaynor; W Gamble
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

5.  A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.

Authors:  Y Huang; A von Eckardstein; S Wu; N Maeda; G Assmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

6.  Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

Authors:  J H Rapp; A Lespine; R L Hamilton; N Colyvas; A H Chaumeton; J Tweedie-Hardman; L Kotite; S T Kunitake; R J Havel; J P Kane
Journal:  Arterioscler Thromb       Date:  1994-11

7.  Absence of triglyceride accumulation in lipoprotein lipase-deficient human monocyte-macrophages incubated with human very low density lipoprotein.

Authors:  S I Skarlatos; H L Dichek; S S Fojo; H B Brewer; H S Kruth
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

8.  High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.

Authors:  M Syvänne; M Ahola; S Lahdenperä; J Kahri; T Kuusi; K S Virtanen; M R Taskinen
Journal:  J Lipid Res       Date:  1995-03       Impact factor: 5.922

9.  Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles.

Authors:  E Cavallero; F Brites; B Delfly; N Nicolaïew; C Decossin; C De Geitere; J C Fruchart; R Wikinski; B Jacotot; G Castro
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-12       Impact factor: 8.311

10.  Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin.

Authors:  J C Mamo; J R Wheeler
Journal:  Coron Artery Dis       Date:  1994-08       Impact factor: 1.439

View more
  1 in total

1.  Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells.

Authors:  Jenny Persson; Jan Nilsson; Marie W Lindholm
Journal:  BMC Immunol       Date:  2008-11-25       Impact factor: 3.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.